Evaluation of 25-hydroxy Vitamin D Serum Levels and Thyroid-related Parameters in Patients with Type 2 Diabetes Mellitus and Healthy People in Shiraz, Iran
Archives of Medical Laboratory Sciences,
Vol. 6 (2020),
20 January 2020
,
Page 1-6 (e22)
https://doi.org/10.22037/amls.v6.31301
Abstract
Background and Aim: The prevalence of type 2 diabetes mellitus (T2DM) is increasing globally. There is increasing evidence in the correlation between altered vitamin D levels, thyroid dysfunction, and T2DM. The goal of this study was to evaluate the association between serum 25-hydroxy vitamin D (25(OH) D), lipid profile, glucose and thyroid-related parameters among patients with T2DM and non-diabetic individuals.
Methods: This case-control study was conducted on 228 individuals (110 type two diabetics and 118 healthy controls). The serum concentration of 25(OH) D was determined by chemiluminescence assay. Photometric methods measured serum levels of fasting blood glucose (FBG), calcium, phosphorous, total Cholesterol (TC), triacylglyceride (TG), high-density lipoprotein (HDL). Low-density lipoprotein (LDL) and VLDL levels were estimated from the Friedewald equation (LDL-C=TC–HDL-C–(TG/5)). The Elisa kit measured serum T4 and TSH.
Results: 80% of Patients with T2DM and 71% of healthy individuals were suffering from vitamin D insufficiency. A non-significant relationship between TG (P=0.36), HDL (P=0.33), VLDL (P=0.36), T4 (P=0.56) calcium (P=0.39) and phosphorus (P=0.41) levels were showed in control and diabetic groups. The levels of FBG (P=0.000), TC (P=0.001), LDL (P=0.004), TSH (P=0.000) were significantly higher, and the levels of 25 (OH) D (P=0.001) was significantly lower in the T2DM group compared to the non-diabetic group.
Conclusion: We revealed that the serum level of 25 (OH) D is lower in patients with T2DM, and the TSH level is significantly higher compared to the non-diabetic group. Thyroid dysfunction and a low level of 25 (OH) D are associated with a high risk of T2DM.
*Corresponding Author: Zakieh Sadat Sheikhalishahi; Email: z.sheikhalishahi@gmail.com
Please cite this article as: Rostami E, Najafi V, Behmard V, Panji M, Moravej FS, Dalvand S, Namdari A, Yavari N, Sheikhalishahi ZS. Evaluation of 25-hydroxy Vitamin D Serum Levels and Thyroid-related Parameters in Patients with Type 2 Diabetes Mellitus and Healthy People in Shiraz, Iran. Arch Med Lab Sci. 2020;6:1-6 (e22). https://doi.org/10.22037/amls.v6.31301
- Type 2 diabetes mellitus
- 25-hydroxy Vitamin D
- High-density lipoprotein
- Low-density lipoprotein
- Thyroid-stimulating hormone
How to Cite
References
Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nature reviews endocrinology. 2012;8(4):228-36.
Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. The Lancet. 2017;389(10085):2239-51.
Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. New England Journal of Medicine. 2015;373(22):2117-28.
Murea M, Ma L, Freedman BI. Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications. The review of diabetic studies: RDS. 2012;9(1):6.
Christakos S, Ajibade DV, Dhawan P, Fechner AJ, Mady LJ. Vitamin D: metabolism. Rheumatic Disease Clinics. 2012;38(1):1-11.
Musavi H, Abazari O, Barartabar Z, Kalaki-Jouybari F, Hemmati-Dinarvand M, Esmaeili P, et al. The benefits of Vitamin D in the COVID-19 pandemic: biochemical and immunological mechanisms. Archives of physiology and biochemistry. 2020:1-9.
Haussler MR, Whitfield GK, Kaneko I, Haussler CA, Hsieh D, Hsieh J-C, et al. Molecular mechanisms of vitamin D action. Calcified tissue international. 2013;92(2):77-98.
Bikle DD. Vitamin D metabolism, mechanism of action, and clinical applications. Chemistry & biology. 2014;21(3):319-29.
Dutta D, Maisnam I, Shrivastava A, Sinha A, Ghosh S, Mukhopadhyay P, et al. Serum vitamin-D predicts insulin resistance in individuals with prediabetes. The Indian journal of medical research. 2013;138(6):853.
Talaei A, Mohamadi M, Adgi Z. The effect of vitamin D on insulin resistance in patients with type 2 diabetes. Diabetology & metabolic syndrome. 2013;5(1):8.
Lips P, Eekhoff M, van Schoor N, Oosterwerff M, de Jongh R, Krul-Poel Y, et al. Vitamin D and type 2 diabetes. The Journal of steroid biochemistry and molecular biology. 2017;173:280-5.
Zare Z, Dizaj TN, Lohrasbi A, Sheikhalishahi ZS, Asadi A, Zakeri M, et al. Silibinin inhibits TGF-β-induced MMP-2 and MMP-9 through Smad Signaling pathway in colorectal cancer HT-29 cells. Basic & Clinical Cancer Research. 2020;12(2):79-88.
Bener A, Ozdenkaya Y, Al-Hamaq AO, Barisik CC, Ozturk M. Low vitamin D deficiency associated with thyroid disease among type 2 diabetic mellitus patients. Journal of clinical medicine research. 2018;10(9):707.
Díez J, Iglesias P. An analysis of the relative risk for hypothyroidism in patients with Type 2 diabetes. Diabetic Medicine. 2012;29(12):1510-4.
Harinarayan CV. Vitamin D and diabetes mellitus. Hormones. 2014;13(2):163-81.
Gutch M, Rungta S, Kumar S, Agarwal A, Bhattacharya A, Razi SM. Thyroid functions and serum lipid profile in metabolic syndrome. biomedical journal. 2017;40(3):147-53.
Abbasi M, Abazari OO. Probing the Biological evaluations of a new designed Palladium (II) complex using spectroscopic and theoretical approaches: Human Hemoglobin as a Target. Archives of Medical Laboratory Sciences. 2018;3(3).
Holick MF. Vitamin D deficiency. New England Journal of Medicine. 2007;357(3):266-81.
Tabesh M, Azadbakht L, Faghihimani E, Tabesh M, Esmaillzadeh A. Effects of calcium–vitamin D co-supplementation on metabolic profiles in vitamin D insufficient people with type 2 diabetes: a randomised controlled clinical trial. Diabetologia. 2014;57(10):2038-47.
Berridge MJ. Vitamin D deficiency and diabetes. Biochemical Journal. 2017;474(8):1321-32.
Marwa A, Amar M. Evaluation of calcium, phosphorus and magnesium level among vitamin d deficient diabetes mellitus patients in Khartoum state. Sch Bull. 2015;1(9):235-41.
Abazari O, Shafaei Z, Divsalar A, Eslami-Moghadam M, Ghalandari B, Saboury AA, et al. Interaction of the synthesized anticancer compound of the methyl-glycine 1, 10-phenanthroline platinum nitrate with human serum albumin and human hemoglobin proteins by spectroscopy methods and molecular docking. Journal of the Iranian Chemical Society. 2020:1-14.
Shirzaiy M, Heidari F, Dalirsani Z, Dehghan J. Estimation of salivary sodium, potassium, calcium, phosphorus and urea in type II diabetic patients. Diabetes & Metabolic Syndrome: clinical research & reviews. 2015;9(4):332-6.
Bozkurt NC, Karbek B, Ucan B, Sahin M, Cakal E, Ozbek M, et al. The association between severity of vitamin D deficiency and Hashimoto's thyroiditis. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2013;19(3):479-84.
Chaker L, Ligthart S, Korevaar TI, Hofman A, Franco OH, Peeters RP, et al. Thyroid function and risk of type 2 diabetes: a population-based prospective cohort study. BMC medicine. 2016;14(1):150.
Chutia H, Bhattacharyya H, Ruram AA, Bora K, Chakraborty M. Evaluation of thyroid function in type 2 diabetes in north-eastern part of India: A hospital-based study. Journal of family medicine and primary care. 2018;7(4):752.
Jun JE, Jee JH, Bae JC, Jin S-M, Hur KY, Lee M-K, et al. Association between changes in thyroid hormones and incident type 2 diabetes: a seven-year longitudinal study. Thyroid. 2017;27(1):29-38.
- Abstract Viewed: 158 times
- PDF Downloaded: 75 times